Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors

Human Gene Therapy

Volumn 17, Issue 3, 2006, Pages 314-320

  Menezes, Kareena M ^a   Mok, Hoyin S ^a,b   Barry, Michael A ^a,b,c,d  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Rice University   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BCM505 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; DYSTROPHIN; FIBROBLAST GROWTH FACTOR 2; GREEN FLUORESCENT PROTEIN; LIGAND; MACROGOL; SOMATOMEDIN; VIRUS RECEPTOR;

ADENOVIRUS 5; ADENOVIRUS VECTOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG CONJUGATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MALE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REPORTER GENE; SKELETAL MUSCLE; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; CROSS-LINKING REAGENTS; FIBROBLAST GROWTH FACTOR 2; GENETIC ENGINEERING; GENETIC VECTORS; IMMUNOCONJUGATES; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; POLYETHYLENE GLYCOLS; SOMATOMEDINS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 33645456196     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.314     Document Type: Article

References (32)

1. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G. (1994). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
2. BOURI, K., FEERO, W.G., MYERBURG, M.M., WICKHAM, T.J., KOVESDI, I., HOFFMAN, E.P., and CLEMENS, P.R. (1999). Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum. Gene Ther. 10, 1633-1640.
3. CAO, B., PRUCHNIC, R., IKEZAWA, M., XIAO, X., LI, J., WICKHAM, T.J., KOVESDI, I., RUDERT, W.A., and HUARD, J. (2001). The role of receptors in the maturation-dependent adenoviral transduction of myofibers. Gene Ther. 8, 627-637.
4. CHENG, Z.Q., ADI, S., WU, N.Y., HSIAO, D., WOO, E.J., FILVAROFF, E.H., GUSTAFSON, T.A., and ROSENTHAL, S.M. (2000). Functional inactivation of the IGF-1 receptor delays differentiation of skeletal muscle cells. J. Endocrinol. 167, 175-182.
5. CROYLE, M.A., YU, Q.C., and WILSON, J.M. (2000). Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum. Gene Ther. 11, 1713-1722.
6. CROYLE, M.A., CHIRMULE, N., ZHANG, Y., and WILSON, J.M. (2001). "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75, 4792-4801.
7. CROYLE, M.A., CHIRMULE, N., ZHANG, Y., and WILSON, J.M. (2002). PEGylation of El-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum. Gene Ther. 13, 1887-1900.
8. ERCK, C., MEISINGER, C., GROTHE, C., and SEIDL, K. (1998). Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J. Cell. Physiol. 176, 22-31.
9. GOSPODAROWICZ, D., WESEMAN, J., and MORAN, J. (1975). Presence in brain of a mitogenic agent promoting proliferation of myoblasts in low density culture. Nature 256, 216-219.
10. ITOH, N., MIMA, T., and MIKAWA, T. (1996). Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development 122, 291-300.
11. KELVIN, D.J., SIMARD, G., SUE-A-QUAN, A., and CONNOLLY, J.A. (1989). Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. II. Two signaling pathways distinguished by pertussis toxin and a potential role for the ras oncogene. J. Cell Biol. 108, 169-176.
12. KOCHANEK, S., CLEMENS, P.R., MITANI, K., CHEN, H.H., CHAN, S., and CASKEY, C.T. (1996). A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 93, 5731-5736.
13. KUMAR-SINGH, R., and CHAMBERLAIN, J.S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5, 913-921.
14. LANCIOTTI, J., SONG, A., DOUKAS, J., SOSNOWSKI, B., PIERCE, G., GREGORY, R., WADSWORTH, S., and O'RIORDAN, C. (2003). Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Mol. Ther. 8, 99-107.
15. LINKHART, T.A., CLEGG, C.H., and HAUSCHKA, S.D. (1981). Myogenic differentiation in permanent clonal myoblast cell lines: Regulation by macromolecular growth factors in the culture medium. Dev. Biol. 105, 48-58.
16. MOK, H., PALMER, D.J., NG, P., and BARRY, M.A. (2005). Evaluation of polyethylene glycol (PEG)-modification of adenoviral vectors to reduce innate immune responses. Mol. Ther. 11, 66-79.
17. MOORE, J.W., DIONNE, C., JAYE, M., and SWAIN, J.L. (1991). The mRNAs encoding acidic FGF, basic FGF and FGF receptor are co-ordinately down regulated during myogenic differentiation. Development 111, 741-748.
18. OGAWARA, K., ROTS, M.G., KOK, R.J., MOORLAG, H.E., VAN LOENEN, A.M., MEIJER, O.K., HAISMA, H.J., and MOLEMA, G. (2004). A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum. Gene Ther. 15, 433-443.
19. OLWIN, B.B., and HAUSHKA, S.D. (1986). Identification of fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. Biochemistry 25, 3487-3492.
20. OLWIN, B.B., and HAUSCHKA, S.D. (1988). Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. J. Cell Biol. 107, 761-769.
21. OLWIN, B.B., and HAUSHKA, S.D. (1990). Fibroblast growth factor levels decrease during chick embryogenesis. J. Cell Biol. 110, 503-509.
22. O'RIORDAN, C.R., LACHAPELLE, A., DELGADO, C., PARKES, V., WADSWORTH, S.C., SMITH, A.E., and FRANCIS, G.E. (1999). PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10, 1349-1358.
23. PARROTT, M.B., ADAMS, K.E., MERCIER, G.T., MOK, H., CAMPOS, S.K., and BARRY, M.A. (2003). Metabolically biotinylated adenovirus for cell-targeting, ligand screening, and vector purification. Mol. Ther. 8, 689-702.
24. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGREN-KRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAND, J.C., PERRICAUDET, M., et al. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
25. ROMANCZUK, H., GALER, C.E., ZABNER, J., BARSOMIAN, G., WADSWORTH, S.C., and O'RIORDAN, C.R. (1999). Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice [see comments]. Hum. Gene Ther. 10, 2615-2626.
26. ROSENTHAL, S.M., BRUNETTI, A., BROWN, E.J., MAMULA, P.W., and GOLDFINE, I.D. (1991). Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation: Potential autocrine role of IGF-II. J. Clin. Invest. 87, 1212-1219.
27. ROSS, M., FRANCIS, G.L., SZABO, L., WALLACE, J.C., and BALLARD, F.J. (1989). Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1. Biochem. J. 258, 267-272.
28. SEWRY, C.A., and PARTRIDGE, T.A. (1996). The muscular dystrophies. In Gene Therapy. Lemoine, A.C., and Cooper, D.N., eds. (BIOS Scientific Publishers, Oxford).
29. TAKAHASHI, S., MOK, H., PARROTT, M.B., MARINI, F.C., ANDREEF, M., BRENNER, M.K., and BARRY, M.A. (2003). Selection of chronic lymphocytic leukemia (CLL) binding peptides. Cancer Res. 63, 5213-5217.
30. TEMPLETON, T.J., and HAUSCHKA, S.D. (1992). FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. Dev. Biol. 154, 169-181.
31. YU, K.T., and CZECH, M.P. (1984). The type I insulin-like growth factor receptor mediates the rapid effects of multiplication-stimulating activity on membrane transport systems in rat soleus muscle. J. Biol. Chem. 259, 3090-3095.
32. 1S transcriptional activity by acting on the cAMP-response element-binding protein element of the promoter region. J. Biol. Chem. 277, 50535-50542.